publication . Article . 2008

Risk factors of the metabolic syndrome in patients with nonalcoholic fatty liver disease.

Uzcátegui, Lilia; Ángel, José Gregorio; Martínez, Dasyl; Gómez Pérez, Roald; Arata de Bellabarba, Gabriela;
Open Access Spanish
  • Published: 15 Jul 2008
  • Publisher: SABER ULA
  • Country: Venezuela
Editorial. Periodismo, mal periodismo, mal de Chagas y ciencias de la salud. Editorial. Journalism, poor journalim, Chagas disease and health sciences. Salinas, Pedro José Cistoadenoma seroso de ovario y embarazo. Reporte de caso. Ovarian serous cystoadenoma and pregnancy. Case report Terán, Penélope; Uribarri, Carolina; Castillo, Sonia y Salinas, Roberto. Factores de riesgo para sindrome metabólico en pacientes con higado graso. Risk factors of the metabolic syndrome in patients with nonalcoholic fatty liver disease. Uzcátegui, Lilia; Ángel, José Gregorio; Martínez, Dasyl; Gómez Pérez, Roald y Arata de Bellabarba, Gabriela Conocimiento de las ventajas y de la t...
free text keywords: Hígado graso no alcohólico, Síndrome metabólico, Ultrasonido, Biopsia hepática, Índice de masa corporal, Perfil bioquímico, Facultad de Medicina, Nonalcoholic fatty liver disease, Hepatic ultrasound, Hepatic biopsy, Metabolic syndrome, Body index mass, Biochemistry profile, Revista MedULA, Artículo [Revista MedULA], Revistas
Related Organizations
16 references, page 1 of 2

NHANES III. 2000. Am Heart J 139: 371-377.

Quinn S, Gosink B. 1985. Characteristic sonographic sings of hepatic fatty infiltration. Am J Roentgenol; 145: 753-755.

Ratziu V, Giral P, Charlotte F et al. 2000. Liver fibrosis in overweight patients. Gastroenterology 118: 1117-1123.

Reaven G. 1995. Pathophysiology of insulin resistance in human disease. Physiol Rev; 75: 473- 486. [OpenAIRE]

Ruderman N, Chisholm D, Pi-Sunyer X. 1998. The metabolically obese, normal-weight individual revisited. Diabetes; 47: 699-713. [OpenAIRE]

Sanyal A. 2002 Treatment of non-alcoholic fatty liver disease. J Gastroenterol Hepatol; 17: S385- S388.

Sargin M, Uygur-Bayaramicli O et al. 2003 Association of nonalcoholic fatty liver disease whit insulin resistance. Is OGTT indicated in nonalcoholic fatty liver disease. J Clin Gastroenterol; 37: 399-402. [OpenAIRE]

Shimada M, Hashimoto E, Taniai M et al. 2002.

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Hepatol; 37: 154-60.

Sorbi D, Boynton J, Lindor K. 1999. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol; 94: 1018-1022. [OpenAIRE]

Willner I, Waters B, Patil S et al. 2001. Ninety patients whit nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. [OpenAIRE]

Am J Gastroenterol; 96: 2957-2961.

Yang S, Lin H, Lane M, et al. 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA; 94: 2557-2562.

Yang S, Lin H, Mandal A, et al. 2001. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34: 694- 706.

Yu A, Keffer B. 2002. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2: 11-19.

16 references, page 1 of 2
Any information missing or wrong?Report an Issue